Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Sales | 403 | 1,686 | 954 | 433 | 478 |
| Cost of Goods | 210 | N/A | 282 | 238 | 266 |
| Gross Profit | 193 | 2,472 | 672 | 195 | 212 |
| Operating Expenses | 11,195 | -8,935 | 7,876 | 8,147 | 6,690 |
| Operating Income | -10,792 | 10,621 | -6,922 | -7,714 | -6,212 |
| Interest Expense | 2 | 257 | 13 | 13 | 12 |
| Other Income | 361 | -904 | 242 | 595 | 233 |
| Pre-tax Income | -10,433 | 9,460 | -6,693 | -7,132 | -5,991 |
| Net Income Continuous | -10,433 | 9,460 | -6,693 | -7,132 | -5,991 |
| Net Income | $-10,433 | $9,460 | $-6,693 | $-7,132 | $-5,991 |
| EPS Basic Total Ops | -25.85 | -387.59 | -17.69 | -19.05 | -17.69 |
| EPS Basic Continuous Ops | -26.45 | -298.52 | -17.61 | -19.38 | -18.05 |
| EPS Diluted Total Ops | -25.85 | -387.59 | -17.69 | -19.05 | -17.69 |
| EPS Diluted Continuous Ops | -26.45 | -298.52 | -17.61 | -19.38 | -18.05 |
| EBITDA(a) | $-10,621 | $10,746 | $-6,604 | $-7,136 | $-6,047 |